Article By:
Jim Van Meerten
Tuesday, February 20, 2024 1:38 PM EDT
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer.
In this article: ZYME
Will Chamath Finally Do A Deal For His IPOF SPAC? (19 Months Later)
I will soon! $VYGG is a SPAC $XAIR due for FDA ruling and $ZYME just rebuffed a takeover bid...